前列腺癌的表观遗传方法:目前的景观和未来的前景
Konstantinos Mesiakaris1, Efthalia Kontogianni1, Souzana Logotheti1
1Department of Pathology, School of Medicine, University of Patras, Greece.
Critical reviews in oncology/hematology
|December 16, 2025
概括
表观遗传改变是前列腺癌 (PCa) 演变和治疗的关键. 本综述强调未充分利用的表观遗传药物和PCa治疗的未来目标,强调其超越传统治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 前列腺癌 (PCa) 的发展和进化并不能完全由遗传学单独解释.
- 人们越来越认识到表观遗传改变是癌症的关键治疗点.
- 目前的PCa治疗方法,如化疗和抗雄激素剥夺有局限性.
研究的目的:
- 审查FDA批准的和癌症治疗的实验性表观遗传策略.
- 评估前列腺癌表观遗传疗法的现状和未来前景.
- 突出PCa在表观遗传药物的临床试验中的不足.
主要方法:
- 对FDA批准和实验性表观遗传剂的审查.
- 对表观遗传疗法临床试验数据的分析,重点关注PCa的纳入.
- 探索新兴的表观遗传目标和策略.
主要成果:
- 表观遗传药物,包括DNA甲基转移酶抑制剂 (DNMTis) 和胰岛素脱乙酶抑制剂 (HDACis),显示出有前途.
- 2020年的批准标志着在固体瘤中进行表观遗传疗法的突破.
- 只有2.57%的表观遗传药物临床研究包括PCa患者,这表明使用不足显著.
结论:
- 表观遗传疗法代表了一个关键的,未被探索的前沿,用于推进前列腺癌治疗.
- 迫切需要新的治疗方法,以针对PCa的表观遗传修饰.
- 药物重新定位和新的表观遗传标为改善PCa结果提供了重大机会.
关键词:
BET 抑制剂是 BET 抑制剂.基因组甲基转移酶抑制剂 (DNMTis) 的使用表观遗传疗法是一种表观遗传疗法.表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.希斯脱乙酶抑制剂 (HDACis) 的使用希斯脱甲基酶是一种素脱甲基酶.基因组甲基转移酶抑制剂 基因组甲基转移酶抑制剂前列腺癌是什么意思 前列腺癌是什么意思更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.0K
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
10.8K
相关概念视频
01:37Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K